Effects of curcumin on bleomycin-induced oxidative stress in malignant testicular germ cell tumors

Molecular Medicine Reports

Volumn 6, Issue 4, 2012, Pages 860-866

  Cort, Aysegul ^a   Ozdemir, Evrim ^a   Timur, Mujgan ^a   Ozben, Tomris ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Bleomycin; Curcumin; Oxidative stress; Reactive oxygen species; Testicular cancer

Indexed keywords

8 ISOPROSTANE; BLEOMYCIN; CARBONYL DERIVATIVE; CURCUMIN; GLUTATHIONE; HYDROGEN PEROXIDE; LIPID HYDROPEROXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL STRESS; CONTROLLED STUDY; GERM CELL TUMOR; HUMAN; HUMAN CELL; MALE; OXIDATIVE STRESS; TESTIS CANCER;

ANTIBIOTICS, ANTINEOPLASTIC; ANTIOXIDANTS; BLEOMYCIN; CELL LINE, TUMOR; CURCUMIN; DINOPROST; GLUTATHIONE; HUMANS; HYDROGEN PEROXIDE; LIPID PEROXIDATION; MALE; NEOPLASMS, GERM CELL AND EMBRYONAL; OXIDATIVE STRESS; PROTEIN CARBONYLATION; TESTICULAR NEOPLASMS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84865184582     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.991     Document Type: Article

References (40)

1. Chieffi P: New prognostic markers and potential therapeutic targets in human testicular germ cell tumors. Curr Med Chem 18: 5033-5040, 2011.
2. de Wit R, Stoter G, Kaye SB, et al: Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group. J Clin Oncol 15: 1837-1843, 1997. (Pubitemid 27209512)
3. Burger RM, Peisach J and Horwitz SB: Activated bleomycin. A transient complex of drug, iron, and oxygen that degrades DNA. J Biol Chem 256: 11636-11644, 1981.
4. Yen CY, Chiu CC, Haung RW, et al: Antiproliferative effects of goniothalamin on Ca9-22 oral cancer cells through apoptosis, DNA damage and ROS induction. Mutat Res 747: 253-258, 2012.
5. Ullah MF, Ahmad A, Zubair H, et al: Soy isoflavone genistein induces cell death in breast cancer cells through mobilization of endogenous copper ions and generation of reactive oxygen species. Mol Nutr Food Res 55: 553-559, 2011.
6. Yu JS and Kim AK: Wogonin induces apoptosis by activation of ERK and p38 MAPKs signaling pathways and generation of reactive oxygen species in human breast cancer cells. Mol Cells 31: 327-335, 2011.
7. Conklin KA: Cancer chemotherapy and antioxidants. J Nutr 134:3201S-3204S, 2004.
8. Nakamura H, Nakamura K and Yodoi J: Redox regulation of cellular activation. Annu Rev Immunol 15: 351-369, 1997. (Pubitemid 27169285)
9. Cantoni O, Cattabeni F, Stocchi V, Meyn RE, Cerutti P and Murray D: Hydrogen peroxide insult in cultured mammalian cells: relationships between DNA single-strand breakage, poly(ADP-ribose) metabolism and cell killing. Biochim Biophys Acta 1014: 1-7, 1989. (Pubitemid 19261593)
10. Kim KY, Yu SN, Lee SY, et al: Salinomycin-induced apoptosis of human prostate cancer cells due to accumulated reactive oxygen species and mitochondrial membrane depolarization. Biochem Biophys Res Commun 413: 80-86, 2011.
11. Bejarano I, Espino J, Marchena AM, et al: Melatonin enhances hydrogen peroxide-induced apoptosis in human promyelocytic leukaemia HL-60 cells. Mol Cell Biochem 353: 167-176, 2011.
12. Ozben T: Oxidative stress and apoptosis: impact on cancer therapy. J Pharm Sci 96: 2181-2196, 2007.
13. Akbas HS, Timur M and Ozben T: Concurrent use of antioxidants in cancer therapy: an update. Expert Rev Clin Immunol 2: 931-939, 2006.
14. Duvoix A, Blasius R, Delhalle S, et al: Chemopreventive and therapeutic effects of curcumin. Cancer Lett 223: 181-190, 2005. (Pubitemid 40719616)
15. Cort A, Timur M, Ozdemir E, Kucuksayan E and Ozben T: Synergistic anticancer activity of curcumin and bleomycin: An in vitro study using human malignant testicular germ cells. Mol Med Rep 5: 1481-1486, 2012.
16. Thomasset SC, Berry DP, Garcea G, Marczylo T, Steward WP and Gescher AJ: Dietary polyphenolic phytochemicals - promising cancer chemopreventive agents in humans? A review of their clinical properties. Int J Cancer 120: 451-458, 2007. (Pubitemid 44969013)
17. Strimpakos AS and Sharma RA: Curcumin: preventive and therapeutic properties in laboratory studies and clinical trials. Antioxid Redox Signal 10: 511-545, 2008.
18. Xu G, Ren G, Xu X, et al: Combination of curcumin and green tea catechins prevents dimethylhydrazine-induced colon carcinogenesis. Food Chem Toxicol 48: 390-395, 2010.
19. Bachmeier B, Nerlich AG, Iancu CM, et al: The chemopreventive polyphenol Curcumin prevents hematogenous breast cancer metastases in immunodeficient mice. Cell Physiol Biochem 19: 137-152, 2007.
20. Watson JL, Hill R, Yaffe PB, et al: Curcumin causes superoxide anion production and p53-independent apoptosis in human colon cancer cells. Cancer Lett 297: 1-8, 2010.
21. Watson JL, Greenshields A, Hill R, et al: Curcumin-induced apoptosis in ovarian carcinoma cells is p53-independent and involves p38 mitogen-activated protein kinase activation and downregulation of Bcl-2 and survivin expression and Akt signaling. Mol Carcinog 49: 13-24, 2010.
22. Aggarwal BB, Banerjee S, Bharadwaj U, Sung B, Shishodia S and Sethi G: Curcumin induces the degradation of cyclin E expression through ubiquitin-dependent pathway and up-regulates cyclin-dependent kinase inhibitors p21 and p27 in multiple human tumor cell lines. Biochem Pharmacol 73: 1024-1032, 2007. (Pubitemid 46283583)
23. Garcea G, Berry DP, Jones DJ, et al: Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol Biomarkers Prev 14: 120-125, 2005. (Pubitemid 40165291)
24. Garcea G, Jones DJ, Singh R, et al: Detection of curcumin and its metabolites in hepatic tissue and portal blood of patients following oral administration. Br J Cancer 90: 1011-1015, 2004. (Pubitemid 38499692)
25. Lao CD, Ruffin MT IV, Normolle D, et al: Dose escalation of a curcuminoid formulation. BMC Complement Altern Med 6: 10, 2006.
26. Cheng AL, Hsu CH, Lin JK, et al: Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res 21: 2895-2900, 2001. (Pubitemid 33051148)
27. Ali EN and Mansour SZ: Boswellic acids extract attenuates pulmonary fibrosis induced by bleomycin and oxidative stress from gamma irradiation in rats. Chin Med 6: 36, 2011.
28. Venkatesan N, Punithavathi V and Chandrakasan G: Curcumin protects bleomycin-induced lung injury in rats. Life Sci 61: PL51-PL58, 1997. (Pubitemid 27303942)
29. Calaf GM, Echiburú-Chau C, Roy D, Chai Y, Wen G and Balajee AS: Protective role of curcumin in oxidative stress of breast cells. Oncol Rep 26: 1029-1035, 2011.
30. Cao J, Jia L, Zhou HM, Liu Y and Zhong LF: Mitochondrial and nuclear DNA damage induced by curcumin in human hepatoma G2 cells. Toxicol Sci 91: 476-483, 2006. (Pubitemid 43827300)
31. Levine RL, Williams JA, Stadtman ER and Shacter E: Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol 233: 346-357, 1994.
32. Biswas J, Sinha D, Mukherjee S, Roy S, Siddiqi M and Roy M: Curcumin protects DNA damage in a chronically arsenicexposed population of West Bengal. Hum Exp Toxicol 29: 513-524, 2010.
33. Dance-Barnes ST, Kock ND, Moore JE, et al: Lung tumor promotion by curcumin. Carcinogenesis 30: 1016-1023, 2009.
34. Biswas J, Roy S, Mukherjee S, Sinha D and Roy M: Indian spice curcumin may be an effective strategy to combat the genotoxicity of arsenic in Swiss albino mice. Asian Pac J Cancer Prev 11: 239-247, 2010.
35. Hilchie AL, Furlong SJ, Sutton K, et al: Curcumin-induced apoptosis in PC3 prostate carcinoma cells is caspase-independent and involves cellular ceramide accumulation and damage to mitochondria. Nutr Cancer 62: 379-389, 2010.
36. Atsumi T, Tonosaki K and Fujisawa S: Comparative cytotoxicity and ROS generation by curcumin and tetrahydrocurcumin following visible-light irradiation or treatment with horseradish peroxidase. Anticancer Res 27: 363-371, 2007.
37. Awasthi S, Pandya U, Singhal SS, et al: Curcumin-glutathione interactions and the role of human glutathione S-transferase P1-1. Chem Biol Interact 128: 19-38, 2000.
38. Usta M, Wortelboer HM, Vervoort J, et al: Human glutathione S-transferase-mediated glutathione conjugation of curcumin and efflux of these conjugates in Caco-2 cells. Chem Res Toxicol 20: 1895-1902, 2007.
39. Koracevic D, Koracevic G, Djordjevic V, Andrejevic S and Cosic V: Method for the measurement of antioxidant activity in human fluids. J Clin Pathol 54: 356-361, 2001. (Pubitemid 32458132)
40. Das L and Vinayak M: Anti-carcinogenic action of curcumin by activation of antioxidant defence system and inhibition of NF-κB signalling in lymphoma-bearing mice. Biosci Rep 32: 161-170, 2012.